Full Text
PND21 COST-EFFECTIVENESS OF RASAGILINE COMPARED TO OTHER FIRST LINE TREATMENT OPTIONS OF EARLY PARKINSONS DISEASE IN THE UNITED STATES

Abstract

Authors

R Farkouh MR Wilson ML Tarrants J Castelli-Haley C Armand

Back to Volume 12, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×